↓ Skip to main content

Dove Medical Press

Berberine hydrochloride: anticancer activity and nanoparticulate delivery system

Overview of attention for article published in International Journal of Nanomedicine, August 2011
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
2 Facebook pages

Readers on

mendeley
114 Mendeley
Title
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
Published in
International Journal of Nanomedicine, August 2011
DOI 10.2147/ijn.s22683
Pubmed ID
Authors

Wen Tan, Yingbo Li, Meiwan Chen, Yitao Wang

Abstract

Berberine hydrochloride is a conventional component in Chinese medicine, and is characterized by a diversity of pharmacological effects. However, due to its hydrophobic properties, along with poor stability and bioavailability, the application of berberine hydrochloride was hampered for a long time. In recent years, the pharmaceutical preparation of berberine hydrochloride has improved to achieve good prospects for clinical application, especially for novel nanoparticulate delivery systems. Moreover, anticancer activity and novel mechanisms have been explored, the chance of regulating glucose and lipid metabolism in cancer cells showing more potential than ever. Therefore, it is expected that appropriate pharmaceutical procedures could be applied to the enormous potential for anticancer efficacy, to give some new insights into anticancer drug preparation in Chinese medicine.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 2 2%
Japan 1 <1%
United States 1 <1%
Malaysia 1 <1%
Unknown 109 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 18%
Student > Master 18 16%
Student > Bachelor 13 11%
Researcher 12 11%
Other 7 6%
Other 14 12%
Unknown 30 26%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 21 18%
Biochemistry, Genetics and Molecular Biology 16 14%
Medicine and Dentistry 16 14%
Agricultural and Biological Sciences 10 9%
Chemistry 8 7%
Other 9 8%
Unknown 34 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2015.
All research outputs
#17,286,379
of 25,374,917 outputs
Outputs from International Journal of Nanomedicine
#2,470
of 4,123 outputs
Outputs of similar age
#93,377
of 130,326 outputs
Outputs of similar age from International Journal of Nanomedicine
#34
of 38 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,123 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 130,326 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.